Veracyte (NASDAQ: VCYT) reported Q1 EPS of ($0.32), $0.01 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $7.48 million versus the consensus estimate of $7.19 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.